985 related articles for article (PubMed ID: 12932235)
1. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Gupta AK; Kohli Y
Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
Gupta AK; Kohli Y; Batra R
Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561
[TBL] [Abstract][Full Text] [Related]
3. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
Bhatia VK; Sharma PC
Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum.
Fernández-Torres B; Vázquez-Veiga H; Llovo X; Pereiro M; Guarro J
Chemotherapy; 2000; 46(6):390-4. PubMed ID: 11053904
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of in vitro activity of ciclopirox olamine, butenafine HCl and econazole nitrate against dermatophytes, yeasts and bacteria.
Kokjohn K; Bradley M; Griffiths B; Ghannoum M
Int J Dermatol; 2003 Sep; 42 Suppl 1():11-7. PubMed ID: 12895182
[TBL] [Abstract][Full Text] [Related]
8. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.
Carrillo-Muñoz AJ; Giusiano G; Cárdenes D; Hernández-Molina JM; Eraso E; Quindós G; Guardia C; del Valle O; Tur-Tur C; Guarro J
Int J Antimicrob Agents; 2008 Jun; 31(6):540-3. PubMed ID: 18367383
[TBL] [Abstract][Full Text] [Related]
9. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
[TBL] [Abstract][Full Text] [Related]
10. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
Sarifakioglu E; Seçkin D; Demirbilek M; Can F
Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
Yenişehirli G; Tunçoğlu E; Yenişehirli A; Bulut Y
Int J Dermatol; 2013 Dec; 52(12):1557-60. PubMed ID: 24134487
[TBL] [Abstract][Full Text] [Related]
12. Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison.
Hazen KC
J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S37-41. PubMed ID: 9594935
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the in vitro activity of terbinafine.
Jessup CJ; Ryder NS; Ghannoum MA
Med Mycol; 2000 Apr; 38(2):155-9. PubMed ID: 10817232
[TBL] [Abstract][Full Text] [Related]
14. [In vitro activity of ketoconazole, itraconazole and terbinafine against Malassezia strains isolated from neonates].
Sancak B; Ayhan M; Karaduman A; Arikan S
Mikrobiyol Bul; 2005 Jul; 39(3):301-8. PubMed ID: 16358489
[TBL] [Abstract][Full Text] [Related]
15. [The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro].
Xu Y; Pang GR; Lü XF; Chen ZJ; Sun ST; Song JZ
Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):309-12. PubMed ID: 16762206
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility testing of dermatophytes--comparison of the agar macrodilution and broth microdilution tests.
Niewerth M; Splanemann V; Korting HC; Ring J; Abeck D
Chemotherapy; 1998; 44(1):31-5. PubMed ID: 9444406
[TBL] [Abstract][Full Text] [Related]
17. Dermatophyte susceptibilities to antifungal azole agents tested in vitro by broth macro and microdilution methods.
Siqueira ER; Ferreira JC; Pedroso RS; Lavrador MA; Candido RC
Rev Inst Med Trop Sao Paulo; 2008; 50(1):1-5. PubMed ID: 18327478
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of antifungal agents against clinical isolates of dermatophytes from animals.
Itoi S; Kano R; Hasegawa A; Kamata H
J Vet Med Sci; 2012 Aug; 74(8):1067-9. PubMed ID: 22467073
[TBL] [Abstract][Full Text] [Related]
19. Combinatorial effect of fluconazole, itraconazole, and terbinafine with different culture extracts of Candida parapsilosis and Trichophyton spp. against Trichophyton rubrum.
Lemes TH; Nascentes JAS; Regasini LO; Siqueira JPZ; Maschio-Lima T; Pattini VC; Ribeiro MD; de Almeida BG; de Almeida MTG
Int Microbiol; 2024 Jun; 27(3):899-905. PubMed ID: 37875749
[TBL] [Abstract][Full Text] [Related]
20. In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
Barchiesi F; Di Francesco LF; Compagnucci P; Arzeni D; Giacometti A; Scalise G
J Antimicrob Chemother; 1998 Jan; 41(1):59-65. PubMed ID: 9511038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]